Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
The stock's fall snapped a four-day winning streak.
We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...
Alphabet and Amazon.com were the latest among Magnificent Seven tech stocks to fall short of guidance forecasts, weighing on ...
The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...
Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Stock futures are little changed as investors aim for a third-straight winning session. Google is the latest tech giant to ...
Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results